发明名称 |
Modulation of insulin like growth factor I receptor expression in cancer |
摘要 |
Provided herein are methods, compounds, and compositions for reducing expression of an IGF-IR mRNA and protein in an animal. Also provided herein are methods, compounds, and compositions that inhibit expression of IGF-IR in an animal. Such methods, compounds, and compositions are useful to treat, prevent, delay, or ameliorate the tumor or cancer, or a symptom thereof. |
申请公布号 |
US9084770(B2) |
申请公布日期 |
2015.07.21 |
申请号 |
US200912578471 |
申请日期 |
2009.10.13 |
申请人 |
Antisense Therapeutics, Ltd. |
发明人 |
Tachas George;Atley Lynne Maree;Wraight Christopher J. |
分类号 |
C12N15/113;A61K31/337;A61K31/7052 |
主分类号 |
C12N15/113 |
代理机构 |
Bozicevic, Field & Francis LLP |
代理人 |
Francis Carol L.;Bozicevic, Field & Francis LLP |
主权项 |
1. A method for enhancing the sensitivity of an IGF-IR positive tumor or cancer cell to a taxane based agent in a subject, the method comprising:
administering to a subject having a taxane based agent-resistant, IGF-IR positive tumor or cancer cell an effective amount of an agent that inhibits expression of IGF-IR. |
地址 |
Toorak AU |